EMT is linked to the properties of cancer stem cells (CSCs), which have been shown to have increased resistance to conventional cancer therapies [44], and in agreement with this notion, we showed that B56γ3 overexpression reduced the sensitivity of CRC cells to 5-FU treatment by upregulating AKT activity (Fig. 6). The gene discussed is AKT1; the disease is cancer.